This inventor holds 1 USPTO granted patent. Top assignee: The Lion Dentifrice Co., Ltd.. Active years: 1980.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1980
Title: Kenkichi Tomita: Innovator in Cancer Treatment
Introduction
Kenkichi Tomita is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel compounds. His work focuses on creating effective agents that can inhibit the growth of cancerous cells.
Latest Patents
Tomita holds a patent for N-(2-Ethylhexyl)-crotonamides, which are novel compounds designed to effectively inhibit the growth of cancerous cells. These compounds are useful as carcinostatic agents, showcasing their potential in cancer therapy. His patent is a testament to his dedication to advancing medical science and improving patient outcomes.
Career Highlights
Throughout his career, Tomita has been associated with The Lion Dentifrice Co., Ltd., where he has contributed to various research initiatives. His work has garnered attention for its innovative approach to cancer treatment, and he continues to be a driving force in the field.
Collaborations
Tomita has collaborated with esteemed colleagues, including Akira Sakuma and Taku Horiuchi. These partnerships have allowed for the exchange of ideas and expertise, further enhancing the impact of their research.
Conclusion
Kenkichi Tomita's contributions to cancer treatment through his innovative compounds highlight the importance of research in the medical field. His dedication to developing effective carcinostatic agents is paving the way for future advancements in cancer therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile